Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years

2 years ago
50

Pfizer and BioNTech announced an analysis that showed that their three-dose coronavirus vaccine regimen indicated a strong immune response in children 6 months to 5 years of age. The analysis reported an efficacy rate of more than 80 percent, and what this could mean for the future of vaccinating toddlers.

Loading 2 comments...